Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

"Your firm failed to clean, maintain, and, as appropriate for the nature of the drug, sanitise and/or sterilise equipment and utensils at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements," the USFDA said.


Post Top Ad